Nano-X Imaging Ltd. (NNOX)
Nano-X Imaging Ltd. is pioneering a digital X-ray source technology aimed at revolutionizing medical imaging. The company's Nanox.ARC system and Nanox.CLOUD platform seek to broaden access to medical screening.
Company Overview
Nano-X Imaging (NNOX) is revolutionizing medical imaging with its innovative digital X-ray technology, Nanox.ARC, and cloud-based Nanox.CLOUD platform, aiming to democratize access to early detection and preventative healthcare on a global scale, targeting a multi-billion dollar market.
Investment Thesis
Nano-X Imaging presents a compelling investment opportunity based on its disruptive digital X-ray technology and its potential to democratize medical imaging. The Nanox.ARC system, coupled with the Nanox.CLOUD platform, aims to significantly reduce the cost and improve the accessibility of medical screening. Successful commercialization of the Nanox.ARC and expansion of the Nanox.CLOUD services, including AI-powered diagnostic tools, are key value drivers. The company's focus on early detection and preventative care aligns with growing global healthcare trends. Achieving regulatory approvals and securing partnerships with healthcare providers are critical milestones. With a market cap of $0.16B and a high beta of 1.35, NNOX offers high-risk, high-reward potential, contingent on successful technology adoption and market penetration.
Key Highlights
- Market Cap of $0.16B reflects the company's current valuation and investor sentiment.
- P/E ratio of -2.82 indicates that the company is not currently profitable, typical for growth-stage companies in the medical device sector.
- Gross Margin of -98.8% highlights the challenges in the early stages of commercialization and the need to scale production efficiently.
- Beta of 1.35 suggests that the stock is more volatile than the market average, reflecting the speculative nature of the technology.
- The company's focus on AI-driven solutions positions it to capitalize on the growing demand for advanced diagnostic tools.
Competitors
Strengths
- Innovative digital X-ray technology.
- Integrated Nanox.ARC system and Nanox.CLOUD platform.
- Potential to disrupt the medical imaging market.
- Focus on early detection and preventative care.
Weaknesses
- Negative profit margin.
- Dependence on regulatory approvals.
- Limited commercial track record.
- High beta, indicating high volatility.
Catalysts
- Upcoming: Regulatory approvals for the Nanox.ARC system in key markets.
- Ongoing: Development and launch of new AI-powered diagnostic tools on the Nanox.CLOUD platform.
- Ongoing: Expansion of strategic partnerships with hospitals and healthcare providers.
- Ongoing: Increasing adoption of teleradiology services.
- Ongoing: Successful commercialization of the Nanox.ARC system and Nanox.CLOUD platform.
Risks
- Potential: Delays in regulatory approvals.
- Ongoing: Competition from established medical imaging companies.
- Potential: Technological obsolescence.
- Ongoing: Reimbursement challenges.
- Potential: Product liability risks.
Growth Opportunities
- Global Expansion: Nano-X has the opportunity to expand its Nanox.ARC system and Nanox.CLOUD platform globally, particularly in underserved markets where access to medical imaging is limited. The global medical imaging market is projected to reach billions of dollars, presenting a significant growth opportunity for Nano-X. Timeline: Ongoing.
- AI-Powered Diagnostics: The development and deployment of AI-powered diagnostic tools on the Nanox.CLOUD platform can enhance the value proposition of the company's offering and attract new customers. These AI solutions can improve the accuracy and efficiency of medical screening, leading to better patient outcomes. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with hospitals, clinics, and healthcare providers can accelerate the adoption of the Nanox.ARC system and expand the company's market reach. These partnerships can provide access to established distribution channels and customer networks. Timeline: Ongoing.
- Teleradiology Services: Expanding teleradiology services can generate recurring revenue and provide a valuable service to imaging facilities and healthcare providers. The demand for teleradiology is growing due to the shortage of radiologists and the increasing volume of medical images. Timeline: Ongoing.
- New Applications: Exploring new applications for the Nanox.ARC system, such as veterinary medicine and industrial imaging, can diversify the company's revenue streams and reduce its reliance on the human healthcare market. These new applications can leverage the unique capabilities of the company's digital X-ray technology. Timeline: Ongoing.
Opportunities
- Global expansion into underserved markets.
- Development of AI-powered diagnostic tools.
- Strategic partnerships with healthcare providers.
- Expansion of teleradiology services.
Threats
- Competition from established medical imaging companies.
- Technological obsolescence.
- Reimbursement challenges.
- Product liability risks.
Competitive Advantages
- Proprietary digital X-ray source technology.
- Integrated Nanox.ARC system and Nanox.CLOUD platform.
- AI-powered diagnostic tools.
- Teleradiology Services.
About
Founded in 2011 and headquartered in Neve Ilan, Israel, Nano-X Imaging Ltd. is dedicated to transforming the medical imaging landscape. The company is developing a commercial-grade tomographic imaging device powered by a digital X-ray source, a departure from traditional analog systems. This innovative approach underpins the Nanox.ARC system, designed to offer a cost-effective and accessible medical screening solution. Complementing the Nanox.ARC is the Nanox.CLOUD, a cloud-based software platform intended to facilitate the delivery of medical screening as a service. Nano-X's vision extends beyond hardware, encompassing the Nanox.MARKETPLACE, a platform connecting imaging facilities with radiologists for remote image interpretation. Furthermore, the company is actively developing artificial intelligence (AI) applications to analyze existing computed tomography scans, aiming to identify or predict undiagnosed conditions such as osteoporosis and cardiovascular disease. Nano-X also offers Teleradiology Services, providing imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Nano-X's integrated ecosystem aims to improve healthcare outcomes through early detection and preventative care, leveraging cutting-edge technology and cloud-based solutions.
What They Do
- Develops a digital X-ray source-based medical imaging system.
- Creates the Nanox.ARC, a medical imaging system.
- Offers Nanox.CLOUD, a cloud-based software platform for medical screening.
- Provides Nanox.MARKETPLACE, connecting imaging facilities with radiologists.
- Develops AI-based software for analyzing medical images.
- Offers Teleradiology Services for remote image interpretation.
- Aims to improve access to medical screening and early detection.
Business Model
- Selling the Nanox.ARC medical imaging system.
- Providing cloud-based medical screening services through Nanox.CLOUD.
- Generating revenue from the Nanox.MARKETPLACE, connecting imaging facilities with radiologists.
- Offering AI-based software solutions for medical image analysis.
- Providing Teleradiology Services for remote image interpretation.
Industry Context
Nano-X Imaging operates within the medical devices industry, a sector characterized by constant innovation and regulatory scrutiny. The market for medical imaging is substantial, driven by an aging population and the increasing prevalence of chronic diseases. Competition includes established players with traditional imaging technologies and emerging companies with novel approaches. Nano-X aims to disrupt the market by offering a more affordable and accessible alternative to conventional X-ray systems. The company's success depends on its ability to navigate the regulatory landscape, secure partnerships, and demonstrate the clinical efficacy of its technology.
Key Customers
- Hospitals and medical clinics.
- Diagnostic imaging centers.
- Urgent care facilities.
- Multi-specialty physician groups.
- Radiology practices.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $3M | -$14M | $-0.21 |
| Q2 2025 | $3M | -$15M | $-0.23 |
| Q1 2025 | $3M | -$13M | $-0.21 |
| Q4 2024 | $3M | -$14M | $-0.23 |
Source: Company filings
Chart & Info
Price Chart
Nano-X Imaging Ltd. (NNOX) stock price: $3.02 (+0.19, +6.71%)
Why Bull
- •Recent insider buying suggests confidence in NNOX's future, indicating that key stakeholders see potential for growth.
- •Community sentiment has shifted positively, with discussions highlighting the company's innovative imaging technology and its potential impact on healthcare.
- •New partnerships announced in the last month have generated excitement, with investors optimistic about expanded market reach and revenue opportunities.
- •Analysts are increasingly recognizing NNOX's unique position in the medical imaging sector, leading to a more favorable outlook among retail investors.
Why Bear
- •Concerns about the company's ability to scale production efficiently have been raised, leading to skepticism about meeting market demand.
- •Negative sentiment has emerged regarding the competitive landscape, with some investors worried about larger players entering the imaging market.
- •Recent quarterly results have not met some investors' expectations, causing a reevaluation of growth projections and dampening enthusiasm.
- •Community discussions reflect caution, with some members expressing doubts about the company's long-term profitability and sustainability in a rapidly evolving industry.
Latest News
-
Sidoti Events, LLC's Year-End Virtual Investor Conference
ACCESS Newswire · Dec 9, 2025
-
Earnings Scheduled For August 12, 2025
benzinga · Aug 12, 2025
-
Earnings Scheduled For May 22, 2025
benzinga · May 22, 2025
-
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
benzinga · Feb 15, 2024
Technical Analysis
Rationale
AI-generated technical analysis for NNOX including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss Nano-X Imaging Ltd. (NNOX) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for NNOX.
Make a Prediction
Set your price target for Nano-X Imaging Ltd. (NNOX), choose a timeframe, and track your prediction accuracy.
Current price: $3.02
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NNOX.
Price Targets
Median: $18.00 (+496.0% from current price)
Insider Flow (30d)
No insider trades in the last 30 days.
MoonshotScore
Score Factors
-
Revenue Growth 4/100
Revenue grew only 13.9% YoY, suggesting the company is in a slower growth phase.
-
Gross Margin 3/100
Gross margin of -98.8% is below average, suggesting thin margins and potential pricing pressure.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Limited cash of $39M could constrain flexibility; watch for dilution risk or debt issuance.
-
R&D Intensity 10/100
Investing 178.9% of revenue in R&D signals heavy commitment to innovation and future product pipeline.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 10/100
Daily turnover of 2.12% indicates healthy liquidity with smooth entry/exit for investors.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates NNOX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Sidoti Events, LLC's Year-End Virtual Investor Conference
Earnings Scheduled For August 12, 2025
Earnings Scheduled For May 22, 2025
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Frequently Asked Questions
What does Nano-X Imaging Ltd. do?
Nano-X Imaging Ltd. is focused on revolutionizing medical imaging through its innovative digital X-ray technology. The company develops, manufactures, and commercializes the Nanox.ARC, a medical imaging system based on a novel digital X-ray source. This system, coupled with the Nanox.CLOUD platform, aims to provide accessible and cost-effective medical screening services. Nano-X also offers AI-based software solutions for analyzing medical images and Teleradiology Services for remote image interpretation. The company's goal is to improve healthcare outcomes through early detection and preventative care, leveraging cutting-edge technology and cloud-based solutions.
Is NNOX stock a good buy?
NNOX stock represents a high-risk, high-reward investment opportunity. The company's innovative technology and potential to disrupt the medical imaging market are compelling factors. However, the company's negative profit margin and dependence on regulatory approvals pose significant risks. Investors should carefully consider their risk tolerance and conduct thorough due diligence before investing in NNOX. Monitoring the company's progress in securing regulatory approvals, expanding its customer base, and achieving profitability is crucial for assessing the long-term investment potential.
What are the main risks for NNOX?
The main risks for Nano-X Imaging include regulatory hurdles, competition, technological obsolescence, and reimbursement challenges. Delays in obtaining regulatory approvals for the Nanox.ARC system could significantly impact the company's commercialization timeline. Competition from established medical imaging companies with greater resources and market share poses a threat. The rapid pace of technological innovation in the medical device industry could render the company's technology obsolete. Furthermore, securing adequate reimbursement for its products and services is essential for driving adoption and generating revenue.
Is NNOX a good stock to buy?
Whether NNOX is a good investment depends on your financial goals, risk tolerance, and investment horizon. Review the Investment Thesis, SWOT analysis, and Risk sections on this page. Always do your own research and consult a financial advisor before investing.
What is the NNOX MoonshotScore?
MoonshotScore is our proprietary AI-powered rating system that evaluates stocks based on growth potential, financial health, market momentum, and risk factors. It helps investors quickly identify high-potential opportunities. Check the MoonshotScore badge on this page for the current rating.
How often is NNOX data updated?
Stock prices are updated in real-time during market hours (9:30 AM - 4:00 PM ET). Company fundamentals, analyst ratings, and AI insights are refreshed daily. News is updated continuously throughout the day.
What are the growth catalysts for NNOX?
Growth catalysts vary by company and may include new product launches, market expansion, earnings surprises, partnerships, or industry tailwinds. Check the Catalysts section on this page for specific drivers relevant to Nano-X Imaging Ltd..
Who are NNOX's main competitors?
Nano-X Imaging Ltd.'s competitors depend on its industry and market segments. Check the Competitors section on this page for a list of direct competitors and how NNOX compares.
What do analysts say about NNOX?
Analyst ratings and price targets for NNOX are aggregated from multiple sources. Check the Analyst Consensus tab for buy/hold/sell ratings and the current consensus price target.
What is NNOX's market cap?
Market capitalization reflects the total market value of NNOX's outstanding shares. Check the Key Statistics section at the top of this page for the current market cap and other key financial metrics.
How has NNOX stock performed recently?
Check the Chart & Info tab for NNOX's recent price action, including daily, weekly, and monthly performance charts with technical indicators.
What are the risks of investing in NNOX?
Every stock carries risk. Check the Risks and Weaknesses sections on this page for NNOX-specific risk factors. Consider macroeconomic conditions, industry trends, and company-specific challenges.
Are insiders buying or selling NNOX?
Insider activity can signal management confidence. Check the Insider Flow tab for recent insider buys, sells, and exercise transactions for NNOX.
Is NNOX a good stock for beginners?
Nano-X Imaging Ltd. (NNOX) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is NNOX for first-time investors?
Every stock carries risk, including Nano-X Imaging Ltd. (NNOX). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like NNOX.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial situation.